Personalized Medicine, Targeted Therapeutics and Companion Diagnostic Market: Strategic Analysis of Industry Trends, Technologies, Participants, and Environment by Kelly Scientific is a comprehensive report and financial forecast to 2025 on the precision medicine industry and its impact on the health system. This report tackles the growing market interest in pharmacogenomics, targeted therapeutics, companion diagnostics and the associated market environment.

Get Free Sample Copy of Personalized Medicine, Targeted Therapeutics and Companion Diagnostic Market to 2025 Research Report at https://www.reportsnreports.com/contacts/requestsample.aspx?name=3330473

In 2019, 11 personalized therapeutics gained approval from the the FDAs Center for Drug Evaluation and Research (CDER) including a gene therapy and a small interfering ribonucleic acid (siRNA) based therapy. Over 20% of all new approvals in 2019 were personalized therapeutics and in 2018 alone, 42% were personalized medicines (25 agents). This was an increase from 34% in 2017 and 27% in 2016. Individualized, targeted or personalized medicine aims to increase the efficacy of therapeutics via genetic testing and companion diagnostics. Personalized therapeutics and associated companion diagnostics will be more specific and effective thereby giving pharma/biotech companies a significant advantage to recuperate R&D costs. Personalized medicine will reduce the frequency of adverse drug reactions and therefore have a dramatic impact on health economics. Developmental and diagnostic companies will benefit from lower discovery and commercialization costs and more specific market subtypes.

This report describes the current technologies that are propelling the Personalized Medicine and Companion Diagnostic Market. It examines the current genetic diagnostic tests and companion diagnostic assays that are in use by the medical and pharmaceutical industry today. Current developments in personalized medicine and the pharmacogenomics revolution are discussed. The emerging trends that appear in key markets such as the US, UK, Germany and France are elucidated and analysed. This study reveals market figures of the overall personalized medicine market and also sub-market figures.

The study also provides a comprehensive financial and product review of key players in the personalized medicine industry. Strategic drivers and restraints of this market are revealed and market opportunities and challenges are identified.

In summary, the personalized therapeutic and associated companion diagnostic market have huge opportunities for growth. This industry is revolutionizing the healthcare system and will improve therapeutic effectiveness and reduce the severity of adverse effects. It has enormous potential for investment and the emergence of genetic-based in vitro diagnostics. This is a comprehensive account of the market size, segmentation, key players, SWOT analysis, influential technologies, and business and economic environments. The report is supported by over 360 tables & figures over 470 pages. The personalized medicine market is presented as follows:

A wealth of financial data & business strategy information is provided including:

Get 20% Discount on this Research Report at https://www.reportsnreports.com/contacts/discount.aspx?name=3330473

SWOT, Economic & Regulatory Environment specifics include:

This report highlights a number of significant players and influential companys and gives details of their operations, products, financials and business strategy.

Updates on the Personalized medicine, targeted therapeutic and companion diagnostic space have been included in this latest edition to include cutting edge material from international conferences, workshops and symposia.

Direct Purchase of Personalized Medicine, Targeted Therapeutics and Companion Diagnostic Market to 2025 Research Report at https://www.reportsnreports.com/purchase.aspx?name=3330473

Countries Covered

Global, US, UK, France, Germany, Spain, Italy, Europe

Table of Contents:

1.0 Executive Summary

2.0 Introduction to Precision/Personalized Medicine

3.0 Personalized Medicine Targeted Therapeutics and Associated Companion Diagnostics

4.0 Personalized Medicine and Integration into the Healthcare System

5.0 Private and Public Funding and Personalized Medicine Reimbursement

6.0 European Personalized Medicine Market Payments and Investment

7.0 Personalized Medicine Business Model Analysis

8.0 Personalized Medicine Main Industry Players

9.0 Personalized Medicine Market Analysis

10.0 Strengths and Advantages of Personalized Medicine

11.0 Restraints of the Personalized Medicine Market

12.0 Personalized Medicine and Regulatory Policies

13.0 Final Summary and Future Perspectives

14.0 Interviews with Key Opinion Leaders

Read the rest here:
Personalized Medicine Market, Targeted Therapeutics and Companion Diagnostic Market to 2025 Key Company Profiles, Trends and Technologies Report - 3rd...

Comments are closed.